Evidence map›Paper›PMID 42859725›Full record

ReviewReviews in cardiovascular medicine2026

Role of Inflammation in the Development of Heart Failure After Myocardial Infarction.

Yachao Li, Mengjie Lei, Zengming Xue

Abstract readReview
In one paragraph

Review in Reviews in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yachao LiLangfang Core Laboratory of Precision Treatment of Coronary Artery Disease, Langfang People's Hospital, 065000 Langfang, Hebei, China.
Mengjie LeiLangfang Core Laboratory of Precision Treatment of Coronary Artery Disease, Langfang People's Hospital, 065000 Langfang, Hebei, China.ORCID https://orcid.org/0000-0001-9940-2488
Zengming XueLangfang Core Laboratory of Precision Treatment of Coronary Artery Disease, Langfang People's Hospital, 065000 Langfang, Hebei, China.ORCID https://orcid.org/0000-0001-9302-9547

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation plays a key role in the onset and progression of heart failure (HF) after myocardial infarction (MI), which represents one of the leading causes of mortality in patients with cardiovascular disease. This review summarizes the inflammatory mechanisms involved at different stages of HF after MI, including the infiltration and activation of inflammatory cells, the release of inflammatory mediators, and the effects of these mediators on cardiomyocytes, the extracellular matrix, and cardiac function. In addition, this review discusses therapeutic strategies that target inflammatory pathways, providing a theoretical basis for the prevention and treatment of HF after MI.

Indexed as

heart failureinflammationmyocardial infarction

Identifiers

PMID42859725
PMCPMC13653198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.